|
 |
ZeaVision is pleased to announce the return of the 10mg zeaxanthin product
|
 |
| St. Louis, MO, April, 2007
:: ZeaVision Adds Two More Prominent Doctors to its Advisory Board. |
|
| St. Louis, MO, August 28, 2006
:: ZeaVision Adds Three Leading Doctors to its Advisory Board. |
|
| St. Louis, MO August 11, 2006
:: Joseph M. Strout named new Chief Financial Officer and member of the Executive Committee for ZeaVision, LLC
|
|
| St. Louis, MO June 2, 2006
::Community Benefits from Eye Studies Conducted by the College of Optometry at the University of Missouri-St. Louis and ZeaVision
|
|
| ST. LOUIS, MO, May 24, 2006
::St. Louis Business Eyes Local Market As First In Country To Screen For AMD Risk
|
|
| May, 2006
::ZeaVision, LLC Announces Three New Business Developments
|
|
|
|
ZeaVision patent Information
|
Patent # 5747544
Method of using pure 3R-3'R stereoisomer of Zeaxanthin to treat or prevent retinal degeneration in humans.
|
Patent # 5854015
Method of making pure 3R-3'R stereoisomer of Zeaxanthin for human ingestion.
|
Patent # RE38009
Zeaxanthin formulation for human ingestion.
|
|